Preparation of hemoglobin-loaded nano-sized particles with porous structure as oxygen carriers.

Hb (hemoglobin)-loaded particles (HbP) encapsulated by a biodegradable polymer used as oxygen carrier were prepared. A modified double emulsion and solvent diffusion/evaporation method was adopted. All experiments were performed based on two types of biodegradable polymers, poly(epsilon-caprolactone) (PCL) and poly(epsilon-caprolactone-ethylene glycol) (PCL-PEG). The biodistribution and the survival time in blood of the particles were investigated in a mouse model. Encapsulation efficiency and pore-connecting efficiency were evaluated by a novel sulfocyanate potassium method. The influence of process parameters on the particle size and pore-connecting efficiency (PCE%) of nanoparticles have been discussed. The prepared conditions: solvent, external aqueous phase, pressure were discussed. The system utilizing dichloromethane (DCM)/ethyl acetate (EA) as a solvent with an unsaturated external aqueous phase yielded the highest encapsulation efficiency (87.35%) with a small mean particle size (153 nm). The formation of porous channels was attributed to the diffusion of solvent. The PCE% was more sensitive to the rate of solvent diffusion that was obviously affected by the preparation temperature. The PCE% reached 87.47% when PCL-PEG was employed at 25 degrees C. P(50) of HbP was 27 mmHg, which does not seem to be greatly affected by the encapsulation procedure. In vivo, following intravenous injection of 6-coumarin labeled HbP, the major organ accumulating Hb-loaded particles was the liver. The half-life of nano-sized PCL HbP was 3.1 times as long as the micro-sized PCL HbP. Also, Nano-sized as well as a PEGylated surface on HbP is beneficial for prolonged blood residence (7.2 fold increase).

[1]  J. D. Hellums,et al.  Effect of hemoglobin polymerization on oxygen transport in hemoglobin solutions. , 2002, Microvascular research.

[2]  E. K. Park,et al.  Preparation and characterization of methoxy poly(ethylene glycol)/poly(epsilon-caprolactone) amphiphilic block copolymeric nanospheres for tumor-specific folate-mediated targeting of anticancer drugs. , 2004, Biomaterials.

[3]  Y. Kawashima,et al.  In vitro drug release behavior of D,L-lactide/glycolide copolymer (PLGA) nanospheres with nafarelin acetate prepared by a novel spontaneous emulsification solvent diffusion method. , 1994, Journal of pharmaceutical sciences.

[4]  A. Lowman,et al.  Biodegradable nanoparticles for drug delivery and targeting , 2002 .

[5]  G. Amiconi,et al.  Measurement of binding of gaseous and nongaseous ligands to hemoglobins by conventional spectrophotometric procedures. , 1981, Methods in enzymology.

[6]  T. Ehtezazi,et al.  Defining the drug incorporation properties of PLA-PEG nanoparticles. , 2000, International journal of pharmaceutics.

[7]  A. Vila,et al.  Transport of PLA-PEG particles across the nasal mucosa: effect of particle size and PEG coating density. , 2004, Journal of controlled release : official journal of the Controlled Release Society.

[8]  T. Chang,et al.  Submicron biodegradable polymer membrane hemoglobin nanocapsules as potential blood substitutes: a preliminary report. , 1994, Artificial cells, blood substitutes, and immobilization biotechnology.

[9]  T. Chang,et al.  Submicron polymer membrane hemoglobin nanocapsules as potential blood substitutes: preparation and characterization. , 1996, Artificial cells, blood substitutes, and immobilization biotechnology.

[10]  J. Reves,et al.  Cardiovascular and Coronary Physiology of Acute Isovolemic Hemodilution: A Review of Nonoxygen‐Carrying and Oxygen‐Carrying Solutions , 1994, Anesthesia and analgesia.

[11]  D A Weitz,et al.  Trojan particles: Large porous carriers of nanoparticles for drug delivery , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[12]  Michel Vert,et al.  Biodistribution of Long-Circulating PEG-Grafted Nanocapsules in Mice: Effects of PEG Chain Length and Density , 2001, Pharmaceutical Research.

[13]  F. Bates,et al.  Polymer vesicles in vivo: correlations with PEG molecular weight. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[14]  M. Prud'homme,et al.  Microspheres based on inulin for the controlled release of serine protease inhibitors: preparation, characterization and in vitro release. , 2003, Journal of Controlled Release.

[15]  T. Chang Blood Substitutes: Principles, Methods, Products, and Clinical Trials , 1998 .

[16]  Robert Gurny,et al.  Preparation and characterization of sterile and freeze-dried sub-200 nm nanoparticles. , 2002, International journal of pharmaceutics.

[17]  Ying Zhang,et al.  A novel microgel and associated post-fabrication encapsulation technique of proteins. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[18]  Jayanth Panyam,et al.  Polymer degradation and in vitro release of a model protein from poly(D,L-lactide-co-glycolide) nano- and microparticles. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[19]  Gordon L. Amidon,et al.  The Mechanism of Uptake of Biodegradable Microparticles in Caco-2 Cells Is Size Dependent , 1997, Pharmaceutical Research.

[20]  T. Kondo,et al.  Liposome-Type Artificial red Blood Cells Stabilized with Carboxymethyl Chitin , 1985 .

[21]  T. Chang,et al.  Two future generations of blood substitutes based on polyhemoglobin-SOD-catalase and nanoencapsulation. , 2000, Advanced drug delivery reviews.

[22]  J. Kreuter Nanoparticles and microparticles for drug and vaccine delivery. , 1996, Journal of anatomy.

[23]  Karsten Mäder,et al.  Investigations on the structure of solid lipid nanoparticles (SLN) and oil-loaded solid lipid nanoparticles by photon correlation spectroscopy, field-flow fractionation and transmission electron microscopy. , 2004, Journal of controlled release : official journal of the Controlled Release Society.

[24]  Z. Su,et al.  Microencapsulation of bovine hemoglobin with high bio-activity and high entrapment efficiency using a W/O/W double emulsion technique , 2004 .

[25]  G. Hardee,et al.  Improvement of the encapsulation efficiency of oligonucleotide-containing biodegradable microspheres. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[26]  T. Chang Recent and future developments in modified hemoglobin and microencapsulated hemoglobin as red blood cell substitutes. , 1997, Artificial cells, blood substitutes, and immobilization biotechnology.

[27]  V. Torchilin,et al.  Activity of amphipathic poly(ethylene glycol) 5000 to prolong the circulation time of liposomes depends on the liposome size and is unfavorable for immunoliposome binding to target. , 1991, Biochimica et biophysica acta.